NCT00122304 Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab Status COMPLETED Phase PHASE3
NCT00112983 Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria Status COMPLETED Phase PHASE3